DOP2018000287A - Método para producir derivado de difenilmetano - Google Patents
Método para producir derivado de difenilmetanoInfo
- Publication number
- DOP2018000287A DOP2018000287A DO2018000287A DO2018000287A DOP2018000287A DO P2018000287 A DOP2018000287 A DO P2018000287A DO 2018000287 A DO2018000287 A DO 2018000287A DO 2018000287 A DO2018000287 A DO 2018000287A DO P2018000287 A DOP2018000287 A DO P2018000287A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- difenylmethane
- producing
- synthesis route
- synthesis
- linear
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B51/00—Introduction of protecting groups or activating groups, not provided for in the preceding groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a un método mejorado para producir un derivado de difenilmetano que es eficaz como inhibidor del cotransportador de glucosa dependiente de sodio (SGLT), el método se lleva a cabo por medio de un método de síntesis convergente en el cual cada grupo principal se sintetiza por separado y luego se acopla. Como tal, en comparación con un método de síntesis lineal descrito en documentos existentes, la ruta de síntesis es compacta y el rendimiento puede aumentarse, y los factores de riesgo inherentes a la ruta de síntesis lineal pueden reducirse. Además, la forma cristalina del compuesto producido de acuerdo con el método tiene excelentes características fisicoquímicas y, por lo tanto, puede utilizarse de manera efectiva en campos como la fabricación farmacéutica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160075910 | 2016-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2018000287A true DOP2018000287A (es) | 2019-03-31 |
Family
ID=60664449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2018000287A DOP2018000287A (es) | 2016-06-17 | 2018-12-17 | Método para producir derivado de difenilmetano |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US10640496B2 (es) |
| EP (2) | EP3663292B1 (es) |
| JP (4) | JP6763978B2 (es) |
| KR (2) | KR102233229B1 (es) |
| CN (2) | CN113651803B (es) |
| AU (1) | AU2017285813B2 (es) |
| BR (1) | BR112018076243A2 (es) |
| CA (2) | CA3081033C (es) |
| CL (1) | CL2018003645A1 (es) |
| CO (1) | CO2018014018A2 (es) |
| DK (2) | DK3663292T3 (es) |
| DO (1) | DOP2018000287A (es) |
| EC (1) | ECSP19000185A (es) |
| ES (2) | ES2898336T3 (es) |
| HR (1) | HRP20211670T8 (es) |
| HU (1) | HUE056428T2 (es) |
| MA (2) | MA44545B2 (es) |
| MX (2) | MX2021008988A (es) |
| NZ (1) | NZ749398A (es) |
| PE (2) | PE20240590A1 (es) |
| PH (1) | PH12018550206A1 (es) |
| PL (2) | PL3663292T3 (es) |
| PT (2) | PT3473621T (es) |
| RS (1) | RS62550B1 (es) |
| SA (1) | SA518400666B1 (es) |
| SG (2) | SG11201811154QA (es) |
| SI (1) | SI3663292T1 (es) |
| TN (1) | TN2018000437A1 (es) |
| WO (1) | WO2017217792A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011054773A1 (de) | 2011-10-25 | 2013-04-25 | Vb Autobatterie Gmbh & Co. Kgaa | Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols |
| MX2021001732A (es) * | 2018-08-13 | 2021-06-23 | Daewoong Pharmaceutical Co Ltd | Preparacion de intermedio util para la sintesis de inhibidor de sglt. |
| CN112341416A (zh) * | 2019-08-09 | 2021-02-09 | 天津津艺医药科技发展有限责任公司 | 一种制备苯并含氧脂杂环衍生物的方法 |
| WO2021172955A1 (ko) | 2020-02-27 | 2021-09-02 | 주식회사 대웅제약 | Sglt 저해제의 합성에 유용한 중간체 및 이를 이용한 sglt 저해제의 제조 방법 |
| CN112094253B (zh) * | 2020-09-10 | 2023-01-10 | 株式会社大熊制药 | 用于制备sglt抑制剂中间体的合成方法 |
| US20230322699A1 (en) | 2020-09-10 | 2023-10-12 | Daewoong Pharmaceutical Co., Ltd. | Synthesis method for preparing sglt inhibitor intermediate |
| CN113200860A (zh) * | 2021-04-29 | 2021-08-03 | 爱斯特（成都）生物制药股份有限公司 | 一种sglt2抑制剂中间体的制备方法 |
| CN113801010A (zh) * | 2021-11-18 | 2021-12-17 | 山东诚创蓝海医药科技有限公司 | 一种5-溴-2-氯苯甲酸的制备方法 |
| CN113912487B (zh) * | 2021-11-23 | 2024-05-28 | 山东研峰新材料科技有限公司 | 一种2,5-双卤代苯甲酸的合成方法 |
| KR20230110001A (ko) * | 2022-01-14 | 2023-07-21 | 주식회사 대웅제약 | Ssglt 저해제의 합성에 유용한 중간체의 제조 방법 |
| KR20240044190A (ko) | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 결정형 및 이의 제조방법 |
| KR20240044194A (ko) | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 공결정 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966907A (en) * | 1988-08-12 | 1990-10-30 | Merck & Co., Inc. | 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis |
| DK2896397T4 (da) * | 2003-08-01 | 2020-11-16 | Mitsubishi Tanabe Pharma Corp | Nye forbindelser med hæmmende aktivitet mod natriumafhængig glukosetransportør |
| EP2183263B1 (en) | 2007-07-26 | 2011-10-26 | Lexicon Pharmaceuticals, Inc. | Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors |
| AR075262A1 (es) | 2008-07-30 | 2011-03-23 | Ferrer Int | Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno, proceso para prepararlos, composicion farmaceutica que los comprende, sus usos como medicamentos, o en tratamientos o prevenciones de condiciones asociadas con un funcionamiento alterado de los sistemas regulados por la melatonina, sus usos para |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| WO2012041898A1 (en) | 2010-09-29 | 2012-04-05 | Celon Pharma Sp. Z O.O. | Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes |
| US9034921B2 (en) * | 2011-06-01 | 2015-05-19 | Green Cross Corporation | Diphenylmethane derivatives as SGLT2 inhibitors |
| US9340521B2 (en) * | 2013-03-18 | 2016-05-17 | Green Cross Corporation | Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives |
| FR3017868A1 (fr) * | 2014-02-21 | 2015-08-28 | Servier Lab | Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2017
- 2017-06-15 BR BR112018076243-1A patent/BR112018076243A2/pt unknown
- 2017-06-15 MA MA44545A patent/MA44545B2/fr unknown
- 2017-06-15 CN CN202110860586.9A patent/CN113651803B/zh active Active
- 2017-06-15 TN TNP/2018/000437A patent/TN2018000437A1/en unknown
- 2017-06-15 WO PCT/KR2017/006271 patent/WO2017217792A1/ko unknown
- 2017-06-15 CN CN201780036968.1A patent/CN109311861B/zh active Active
- 2017-06-15 AU AU2017285813A patent/AU2017285813B2/en active Active
- 2017-06-15 MX MX2021008988A patent/MX2021008988A/es unknown
- 2017-06-15 MX MX2018015647A patent/MX2018015647A/es unknown
- 2017-06-15 DK DK20152959.1T patent/DK3663292T3/da active
- 2017-06-15 MA MA50774A patent/MA50774B1/fr unknown
- 2017-06-15 JP JP2018565754A patent/JP6763978B2/ja active Active
- 2017-06-15 KR KR1020170075799A patent/KR102233229B1/ko active Protection Beyond IP Right Term
- 2017-06-15 RS RS20211297A patent/RS62550B1/sr unknown
- 2017-06-15 ES ES20152959T patent/ES2898336T3/es active Active
- 2017-06-15 DK DK17813615.6T patent/DK3473621T3/da active
- 2017-06-15 SG SG11201811154QA patent/SG11201811154QA/en unknown
- 2017-06-15 NZ NZ749398A patent/NZ749398A/en unknown
- 2017-06-15 HU HUE20152959A patent/HUE056428T2/hu unknown
- 2017-06-15 CA CA3081033A patent/CA3081033C/en active Active
- 2017-06-15 HR HRP20211670TT patent/HRP20211670T8/hr unknown
- 2017-06-15 SI SI201730944T patent/SI3663292T1/sl unknown
- 2017-06-15 ES ES17813615T patent/ES2891825T3/es active Active
- 2017-06-15 EP EP20152959.1A patent/EP3663292B1/en active Active
- 2017-06-15 US US16/310,005 patent/US10640496B2/en active Active
- 2017-06-15 PL PL20152959T patent/PL3663292T3/pl unknown
- 2017-06-15 PT PT17813615T patent/PT3473621T/pt unknown
- 2017-06-15 CA CA3026756A patent/CA3026756C/en active Active
- 2017-06-15 PT PT201529591T patent/PT3663292T/pt unknown
- 2017-06-15 PE PE2023002240A patent/PE20240590A1/es unknown
- 2017-06-15 SG SG10201911782RA patent/SG10201911782RA/en unknown
- 2017-06-15 PE PE2018003162A patent/PE20190467A1/es unknown
- 2017-06-15 PL PL17813615T patent/PL3473621T3/pl unknown
- 2017-06-15 EP EP17813615.6A patent/EP3473621B1/en active Active
-
2018
- 2018-12-15 SA SA518400666A patent/SA518400666B1/ar unknown
- 2018-12-17 PH PH12018550206A patent/PH12018550206A1/en unknown
- 2018-12-17 CL CL2018003645A patent/CL2018003645A1/es unknown
- 2018-12-17 DO DO2018000287A patent/DOP2018000287A/es unknown
- 2018-12-21 CO CONC2018/0014018A patent/CO2018014018A2/es unknown
-
2019
- 2019-01-04 EC ECSENADI2019185A patent/ECSP19000185A/es unknown
- 2019-08-30 US US16/557,180 patent/US10889574B2/en active Active
-
2020
- 2020-04-06 JP JP2020068458A patent/JP7352509B2/ja active Active
-
2021
- 2021-03-22 KR KR1020210036824A patent/KR102379584B1/ko active IP Right Grant
- 2021-06-21 JP JP2021102648A patent/JP2021152054A/ja active Pending
-
2023
- 2023-07-06 JP JP2023111632A patent/JP2023145481A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2018000287A (es) | Método para producir derivado de difenilmetano | |
| CL2021001266A1 (es) | Síntesis mejorada del intermedio clave del compuesto inhibidor de g12c de kras | |
| CL2019000844A1 (es) | Compuesto de piridina. | |
| BR112016012883A2 (pt) | Métodos e composições para aprimorar o rendimento de milho | |
| CO7141404A2 (es) | Procesos para producir ciertos 2 (piridin 3 il)tiazoles | |
| CO7141403A2 (es) | Procesos para producir ciertos 2 (piridin 3 il)tiazoles | |
| EA201500738A1 (ru) | Способ получения замещенных оксиранов и триазолов | |
| CO6640282A2 (es) | Barra de limpieza que comprende arcilla y/o talco | |
| CR20140071A (es) | Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa | |
| CL2019002297A1 (es) | Inhibidores de mnk sustituidos con piperidina y métodos relacionados con los mismos. | |
| BR112013025797A2 (pt) | processo para produzir um óleo mineral | |
| MX2016013557A (es) | Produccion de 4-metil-tetrahidropiranos 2-sustituidos a partir de materiales de partida con contenido de 2-alquil-4,4-dimetil-1,3-di oxanos. | |
| EA201501030A1 (ru) | Новые отвердители и разлагаемые полимеры и композиты на их основе | |
| GB201319839D0 (en) | Synthesis and use of glycoside derivatives of propofol | |
| CU20160003A7 (es) | Pirazololpiridinaminas sustituidas | |
| EA201691006A1 (ru) | Морфологические формы гексадецилоксипропиловых сложных эфиров фосфоновой кислоты и способы их синтеза | |
| AR095669A1 (es) | Toxinas, composiciones y métodos relacionados | |
| EA201690245A1 (ru) | Оптимизированный способ получения композиции, содержащей изомальтулозу | |
| CO7141402A2 (es) | Procesos para producir ciertos 2 (piridin 3 il)tiazoles | |
| CL2022001806A1 (es) | Método para producir derivado de difenilmetano. | |
| UA109695C2 (uk) | Збиральний пристрій для збиральної машини (варіанти) | |
| CL2014001043A1 (es) | Procedimiento para preparar un compuesto intermediario en la ruta de sintesis de tmc 435, inhibidor de proteasa, útil en el tratamiento de la hepatitis c. | |
| CR20150366A (es) | Métodos para incrementar el rendimiento de los cultivos | |
| IN2013MU01219A (es) | ||
| AR102166A1 (es) | Método de fabricación de un péptido derivado de tapsigargina |